On September 1 (Monday) another meeting of the Transparency Council.
The agenda includes:
Preparation of drug assessment positions:
• Onureg (azacitidine) as part of the B.114 drug...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
